Language selection

Search

2011-03-29 - Female - 38 Years old

365186

Adverse reaction report number 365186
Latest AER version number 0
Market authorization holder AER number N/A
Initial received date 2011-03-29
Latest received date 2011-03-29
Age 38 Years
Gender Female
Weight N/A
Type of report Spontaneous
Reporter type Consumer Or Other Non Health Professional
Source of report Community
Report outcome Unknown
Serious report? Yes

Reason for seriousness

Death
Disability
Cogenital anomaly
Life threateting
Hospitalization Yes
Other medically important

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XR 30MGCAPSULE, EXTENDED RELEASESuspectOral30 Milligram1 every 1 Day(s) Attention deficit/hyperactivity disorder
ATIVANNOT SPECIFIEDConcomitantUnknown

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Myocardial infarction
Date modified: